CareLit · DOI-Nachweis · Aktuelle Neurologie
European-Huntington-Disease-Initiative (EHDI)-Study: Effect of riluzole on disease progression
DOI 10.1055/s-2005-919710
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA.C Ludolph, B Landwehrmeyer, J Garcia de Yebenes, B Dubois, H.P.H Kremer, H Przuntek, W Gaus, M Dib, W Fischer
ZeitschriftAktuelle Neurologie
Ausgabe10/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Riluzole has been shown to modify disease progression in amyotrophic lateral sclerosis (ALS) resulting in improved survival rates compared to controls. First studies in a transgenic mouse model of HD indicated an increase in survival time for these mice under riluzole and a fragmentation of neuronal intranuclear inclusions. Wether riluzole has an effect in HD patients in slowing down the disease progression was stud…
Zitieren
Zitierempfehlung
A.C Ludolph, B Landwehrmeyer, J Garcia de Yebenes, B Dubois, H.P.H Kremer, H Przuntek, W Gaus, M Dib, W Fischer (2005) European-Huntington-Disease-Initiative (EHDI)-Study: Effect of riluzole on disease progression. Aktuelle Neurologie (10). https://doi.org/10.1055/s-2005-919710
Mit CareLit weiterarbeiten